CompletedNCT01351272
Official study titleGenetic Modulation of Functional Brain Activity of Attention-deficit/Hyperactivity Disorder-related Working Memory Processes
This study has finished and is no longer accepting participants.
In WürzburgADHDMedication studyAges 18–50
- Countries
- Germany
- Sponsor
- Wuerzburg University Hospital
CompletedNCT05296473
Official study titleGuided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Randomized, Controlled, Parallel-group, Intervention Study to Assess an At-home, Game-based Digital Therapy for Treating Adult Patients With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleADHDDevice studyAges 22–55
- Countries
- United States
- Sponsor
- Lumos Labs, Inc.
UnknownNCT06406335
Current recruitment status is unconfirmed.
In CairoADHDInterventional studyAges 6–9
- Countries
- Egypt
- Sponsor
- Ain Shams University
CompletedNCT03692728
Official study titleIncreased Risk of Attention Deficit Hyperactivity Disorder Among Children With Bilateral Congenital Cataracts
This study has finished and is no longer accepting participants.
In GuangzhouADHDObservational studyAges 3–8
- Countries
- China
- Sponsor
- Sun Yat-sen University
Active Not RecruitingNCT05700539
About this title
Internet-based Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
Read the official source — NCT05700539Official study titleA Randomized Controlled Trial of Internet-based Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder in Sweden
This study is no longer accepting new participants.
In UppsalaADHDBehavioural studyAges 18+
- Countries
- Sweden
- Sponsor
- Karolinska Institutet
CompletedNCT03292952
Official study titleA Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BradentonADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Zevra Therapeutics
CompletedNCT03460652
Official study titleA Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Zevra Therapeutics
CompletedNCT05518435
Official study titleManaging Young People With Attention Deficit Hyperactivity Disorder in Primary Care (MAP) Study: Mapping Current Practice and Co-producing Guidance to Improve Healthcare in an Underserved Population
This study has finished and is no longer accepting participants.
In ExeterADHDObservational studyAges 16+
- Countries
- United Kingdom
- Sponsor
- University of Exeter
CompletedNCT00015054
Official study titleMPD04961-Methylphendidate Treatment of Cocaine Dependent ADHD Patients
This study has finished and is no longer accepting participants.
In CincinnatiADHDMedication studyAges 21–50
- Countries
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
CompletedNCT00015223
Official study titleMethyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD
This study has finished and is no longer accepting participants.
In CincinnatiADHD, AddictionMedication studyAges 21–50
- Countries
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
CompletedNCT05937347
Official study titleMindfulness and Cognitive Training Programs for Children with Attention Deficit Hyperactivity Disorder (ADHD): a Randomized, Controlled Trial (the NeuroMind Study)
This study has finished and is no longer accepting participants.
In Esplugues de LlobregatADHDBehavioural studyAges 7–12
- Countries
- Spain
- Sponsor
- Fundació Sant Joan de Déu
CompletedNCT02463396
Official study titleMindfulness Training Versus Treatment as Usual in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In NijmegenADHDBehavioural studyAges 18+
- Countries
- Netherlands
- Sponsor
- Radboud University Medical Center